OncoPrecision

OncoPrecision is developing high-throughput screening technology capable of accurately predicting cancer patients' responses to various therapies and modalities within clinically relevant turnaround times, significantly improving outcomes for cancer patients. By collaborating from the early stages of drug development to clinical prescription, we are seeking ways to improve the lives of current and future cancer patients.